Liver transplantation and neurological side effects.
Advances in liver transplantation (LT), particularly in immunosuppression and intensive care treatment have had increased the number of long-term survivors following liver transplantation. In order of more long-term survivors, reports about neurological complication following liver transplantation are increasing. Neurological complications are not uncommon in liver transplant recipients, which contribute to a longer ICU- and in-hospital stay. Every effort should be focused on early detection to prevent the patient from this life-threatening event, which is often associated with poor life quality.
Saner
Fuat H
FH
Department of General-, Visceral and Transplant Surgery, University Hospital Essen, Hufelandstr. 55, 45122 Essen, Germany. fuat.saner@uni-due.de
Nadalin
Silvio
S
Radtke
Arnold
A
Sotiropoulos
Georgios C
GC
Kaiser
Gernot M
GM
Paul
Andreas
A
D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D019703:Calcineurin / Q000378:metabolism; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000009:adverse effects*; D042241:Early Diagnosis; D006501:Hepatic Encephalopathy / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016031:Liver Transplantation / Q000009:adverse effects*; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000503:physiopathology*; D011183:Postoperative Complications / Q000139:chemically induced / Q000209:etiology / Q000503:physiopathology; D016559:Tacrolimus / Q000009:adverse effects*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019703:Calcineurin; D016559:Tacrolimus